Ma Hui, Li Zhongchen, Yuan Jia, Zhang Lan, Xie Xiaoying, Yin Xin, Chen Rongxin, Ren Zhenggang
Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.
Gastroenterol Res Pract. 2021 Jan 2;2021:8878417. doi: 10.1155/2021/8878417. eCollection 2021.
Recurrence after curative resection for hepatocellular carcinoma (HCC) is a major cause of death from this disease. Factors of primary curative resection are available and potential in the prognosis of follow-up treatment. Our aim was to assess the prognostic significance of primary curative resection factors in recurrent HCC patients undergoing radiofrequency ablation therapy (RFA).
In this retrospective study, we assessed 235 patients who underwent limited RFA of HCC recurrences (tumors ≤ 5 cm; nodules ≤ 3) after primary curative resection. Factors of primary curative resection were collected, and overall survival and recurrence-free survival were evaluated by the Kaplan-Meier method. Univariate and multivariate analyses were used to identify significant prognostic factors.
After a median follow-up of 36 months, 54 patients died, and 128 patients had hepatic recurrence. On univariate analyses, patients whose primary tumors were less differentiated ( = 0.032 and = 0.048) and required less time to recur ( = 0.013 and = 0.001) after curative resection displayed poorer overall survival and higher recurrence rates following RFA. On multivariate analyses, the pathologic tumor grade ( = 0.026 and = 0.038) and recurrence-free survival after primary curative resection ( = 0.028 and < 0.001) emerged as independent risk factors of survival and HCC recurrence.
Primary tumor differentiation and time to recurrence after curative resection are viable prognostic factors of overall survival and further recurrence risk in patients undergoing RFA of recurrent HCC.
肝细胞癌(HCC)根治性切除术后复发是导致该病死亡的主要原因。原发性根治性切除的因素对于后续治疗的预后具有参考价值和潜在意义。我们的目的是评估原发性根治性切除因素对接受射频消融治疗(RFA)的复发性HCC患者的预后意义。
在这项回顾性研究中,我们评估了235例在原发性根治性切除术后接受局限性RFA治疗HCC复发(肿瘤≤5 cm;结节≤3个)的患者。收集原发性根治性切除的因素,并采用Kaplan-Meier法评估总生存期和无复发生存期。采用单因素和多因素分析来确定显著的预后因素。
中位随访36个月后,54例患者死亡,128例患者出现肝复发。单因素分析显示,原发性肿瘤分化程度较低(P = 0.032和P = 0.048)且根治性切除后复发所需时间较短(P = 0.013和P = 0.001)的患者,RFA治疗后的总生存期较差,复发率较高。多因素分析显示,病理肿瘤分级(P = 0.026和P = 0.038)以及原发性根治性切除后的无复发生存期(P = 0.028和P < 0.001)是生存和HCC复发的独立危险因素。
原发性肿瘤分化程度和根治性切除后复发时间是接受复发性HCC RFA治疗患者总生存期和进一步复发风险的可行预后因素。